NUPR1 and pancreatic neoplasm: We8,14 and others15–19 have shown that genetic inactivation of Nupr1 antagonizes the growth of tumors in several tissues, including pancreatic cancer8 thereby supporting a role for this protein as a promising therapeutic target for the development of therapies for pancreatic cancer.